KXV01 Lentinvivo (TCR) Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KXV01 Lentinvivo (TCR) Injection, covering 2025-12-10 to 2025-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors [Phase 1]